NO20033049L - Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin - Google Patents
Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidinInfo
- Publication number
- NO20033049L NO20033049L NO20033049A NO20033049A NO20033049L NO 20033049 L NO20033049 L NO 20033049L NO 20033049 A NO20033049 A NO 20033049A NO 20033049 A NO20033049 A NO 20033049A NO 20033049 L NO20033049 L NO 20033049L
- Authority
- NO
- Norway
- Prior art keywords
- fluorophenyl
- trans
- methylpiperidine
- hydroxymethyl
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- CXRHUYYZISIIMT-AAEUAGOBSA-N [(3s,4r)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methanol Chemical compound OC[C@@H]1CN(C)CC[C@H]1C1=CC=C(F)C=C1 CXRHUYYZISIIMT-AAEUAGOBSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 abstract 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- FAHGZANUNVVDFL-HYBUGGRVSA-N omiloxetine Chemical compound C1=CC(F)=CC=C1[C@@H]1[C@@H](COC=2C=C3OCOC3=CC=2)CN(CC(=O)C=2C=CC(F)=CC=2)CC1 FAHGZANUNVVDFL-HYBUGGRVSA-N 0.000 abstract 1
- 229950005637 omiloxetine Drugs 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2001/000049 WO2002053537A1 (fr) | 2001-01-04 | 2001-01-04 | Procede de preparation de (?)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033049D0 NO20033049D0 (no) | 2003-07-03 |
| NO20033049L true NO20033049L (no) | 2003-08-18 |
Family
ID=8164242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033049A NO20033049L (no) | 2001-01-04 | 2003-07-03 | Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6881845B2 (fr) |
| EP (1) | EP1347960B1 (fr) |
| JP (1) | JP2004520333A (fr) |
| KR (1) | KR20030067742A (fr) |
| AT (1) | ATE282594T1 (fr) |
| BR (1) | BR0116721A (fr) |
| CA (1) | CA2433605A1 (fr) |
| DE (1) | DE60107292T2 (fr) |
| DK (1) | DK1347960T3 (fr) |
| ES (1) | ES2232588T3 (fr) |
| IL (1) | IL156768A0 (fr) |
| MX (1) | MXPA03006057A (fr) |
| NO (1) | NO20033049L (fr) |
| NZ (1) | NZ526874A (fr) |
| PT (1) | PT1347960E (fr) |
| TW (1) | TW593279B (fr) |
| WO (1) | WO2002053537A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9087301A (en) * | 2000-09-11 | 2002-03-26 | Sepracor Inc | Ligands for monoamine receptors and transporters, and methods of use thereof |
| DE10240026A1 (de) * | 2002-08-27 | 2004-03-11 | Merck Patent Gmbh | Verfahren zur Herstellung von Monoalkylaminoketonen |
| WO2004043921A1 (fr) * | 2002-11-11 | 2004-05-27 | Natco Pharma Limited | Nouveau procede de preparation de 4-aryl-3-hydroxymethyl-1-methylpiperidines |
| WO2005063707A1 (fr) * | 2003-12-26 | 2005-07-14 | Natco Pharma Limited | Procede enantiospecifique permettant de preparer un intermediaire de paroxetine |
| WO2007089193A1 (fr) * | 2006-02-02 | 2007-08-09 | Astrazeneca Ab | Procédé de synthèse du 2-hydroxy-3-[5-(morpholin-4-ylméthyl)pyridin-2-yl]1h-indole-5-carbonitrile sous forme de base libre ou de ses sels |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
| WO2022269643A1 (fr) * | 2021-06-25 | 2022-12-29 | Vihita Chem Private Limited | Procédé amélioré pour la préparation d'un intermédiaire pour la paroxétine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| EP0223334B1 (fr) * | 1985-08-10 | 1991-07-10 | Beecham Group Plc | Procédé de préparation d'aryl-pipéridine-carbinols |
| DK715988D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Etherifikation og dealkylering af piperidin-derivater samt intermediater |
| CA2220963A1 (fr) * | 1995-05-17 | 1996-11-21 | Novo Nordisk A/S | Procede de preparation de derives de 4-arylpiperidine |
| EP1384720A1 (fr) * | 1996-06-13 | 2004-01-28 | SUMIKA FINE CHEMICALS Co., Ltd. | Procédé de séchage pour le chlorhydrate de paroxetine |
| IL133140A0 (en) * | 1997-05-29 | 2001-03-19 | Smithkline Beecham Corp | Novel process for the preparation of 4-aryl-piperidines |
| WO2000026187A1 (fr) * | 1998-11-02 | 2000-05-11 | Synthon B.V. | Procede de production de 4-arylpiperidine-3-carbinols et composes correspondants |
-
2001
- 2001-01-04 KR KR10-2003-7009058A patent/KR20030067742A/ko not_active Ceased
- 2001-01-04 JP JP2002554656A patent/JP2004520333A/ja not_active Abandoned
- 2001-01-04 CA CA002433605A patent/CA2433605A1/fr not_active Abandoned
- 2001-01-04 NZ NZ526874A patent/NZ526874A/en unknown
- 2001-01-04 BR BR0116721-9A patent/BR0116721A/pt not_active IP Right Cessation
- 2001-01-04 WO PCT/EP2001/000049 patent/WO2002053537A1/fr not_active Ceased
- 2001-01-04 DE DE60107292T patent/DE60107292T2/de not_active Expired - Fee Related
- 2001-01-04 EP EP01901146A patent/EP1347960B1/fr not_active Expired - Lifetime
- 2001-01-04 ES ES01901146T patent/ES2232588T3/es not_active Expired - Lifetime
- 2001-01-04 AT AT01901146T patent/ATE282594T1/de not_active IP Right Cessation
- 2001-01-04 MX MXPA03006057A patent/MXPA03006057A/es not_active Application Discontinuation
- 2001-01-04 PT PT01901146T patent/PT1347960E/pt unknown
- 2001-01-04 US US10/250,519 patent/US6881845B2/en not_active Expired - Fee Related
- 2001-01-04 DK DK01901146T patent/DK1347960T3/da active
- 2001-01-04 IL IL15676801A patent/IL156768A0/xx unknown
- 2001-02-27 TW TW090104450A patent/TW593279B/zh not_active IP Right Cessation
-
2003
- 2003-07-03 NO NO20033049A patent/NO20033049L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6881845B2 (en) | 2005-04-19 |
| JP2004520333A (ja) | 2004-07-08 |
| NZ526874A (en) | 2005-07-29 |
| ATE282594T1 (de) | 2004-12-15 |
| EP1347960B1 (fr) | 2004-11-17 |
| WO2002053537A1 (fr) | 2002-07-11 |
| DE60107292D1 (de) | 2004-12-23 |
| DK1347960T3 (da) | 2005-03-21 |
| MXPA03006057A (es) | 2004-01-26 |
| EP1347960A1 (fr) | 2003-10-01 |
| KR20030067742A (ko) | 2003-08-14 |
| ES2232588T3 (es) | 2005-06-01 |
| DE60107292T2 (de) | 2005-12-01 |
| WO2002053537A8 (fr) | 2002-08-08 |
| PT1347960E (pt) | 2005-03-31 |
| BR0116721A (pt) | 2003-12-23 |
| NO20033049D0 (no) | 2003-07-03 |
| TW593279B (en) | 2004-06-21 |
| US20040215020A1 (en) | 2004-10-28 |
| IL156768A0 (en) | 2004-02-08 |
| CA2433605A1 (fr) | 2002-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE297203T1 (de) | Antithrombotische mitteln | |
| NL300877I2 (nl) | obeticholzuur | |
| DE69831868D1 (en) | Antithrombosemittel | |
| PL367105A1 (en) | Quinoline derivative having azolyl group and quinazoline derivative | |
| EE05453B1 (et) | Protsess asetidinoonvahehendite valmistamiseks | |
| ZA200309887B (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
| DE69915004D1 (de) | 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate | |
| MXPA04001323A (es) | Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso. | |
| EA200300982A1 (ru) | Гетероциклические производные для лечения рака и других пролиферативных заболеваний | |
| YU94103A (sh) | Novi derivati sulfonske kiseline | |
| DE60228724D1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
| DE60114640D1 (en) | Antithrombosemittel | |
| NO20033049D0 (no) | Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1 | |
| MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
| DE60235365D1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
| DE60224884D1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
| MXPA04003086A (es) | Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos. | |
| YU62302A (sh) | Postupak za izradu jedinjenja 2-(4-alkil-1-piperazinil)- benzaldehida i benzilidenila | |
| DK1320527T3 (da) | Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler | |
| SE0103646D0 (sv) | Therapeutic chroman compounds | |
| SE9901237D0 (sv) | Novel use |